Cancer common after liver transplantation

NEW YORK (Reuters Health) - People who undergo liver transplantation, particularly children, are at increased risk for developing cancer, Finnish researchers report in the journal Liver Transplantation.

“On the basis of our data,” Dr. Fredrik Aberg, from the Helsinki University Central Hospital, and co-authors note, “1 of 6 liver transplant patients is estimated to develop some form of cancer by 20 years after transplantation.”

Although post-transplant cancer are a recognized problem, “more studies are needed to obtain reliable data on cancer risk patterns in an attempt to reach consensus on optimal monitoring of (immune-suppressing drugs), cancer surveillance programs, and strategies to minimize cancer risk,” the authors maintain.

Their study included all 540 patients who received liver transplants at Aberg’s center between 1982 and 2005, linked with the nationwide Finnish Cancer Registry. During follow-up, 39 cancers developed in 36 patients, which translates into a 2.59-fold increased risk relative to that seen in the general population.

Rates were higher among children younger than 17 years of age than among older patients. The cancers developed anywhere from 4 months to 14 years after the transplant operation.

Further analysis showed that only non-Hodgkin lymphoma, a cancer of the body’s infection-fighting lymphatic system, and certain types of skin cancer were more common in liver transplant recipients than in the general population.

Risk factors for skin cancer were older age and the type of immune-suppressing drugs received, while those for non-Hodgkin lymphoma were male gender, young age, and the immediate post-transplant period.

Aberg’s team, “This study points out the importance of cancer surveillance after liver transplantation as well as the need for innovative immunosuppression strategies associated with less cancer risk.”

SOURCE: Liver Transplantation, October 2008.


Related Posts:

NEW YORK (Reuters Health) - New research indicates that most children who are 5-year survivors of liver transplantation have good graft function; however, chronic medical conditions and complications affecting other organs are common in this patient population. “The success of liver transplantation in children is defined by more than just excellent survival rates. Better understanding of

Full Post: Children do well 5 years after liver transplant

NEW YORK (Reuters Health) - An organ allocation policy that puts the sickest patients first in line to receive available donor livers for transplantation has created some unintended consequences for those patients low on the organ wait list, research suggests. Since the new donor organ allocation system was implemented in early 2002, there has been a

Full Post: Policy has changed how organs are allocated

By Will Boggs, MD NEW YORK (Reuters Health) - People hoping for a liver transplant and who are obese face prolonged waiting times, reflecting a possible “reluctance to transplant obese patients,” according to a new report. “In transplantation, outcomes are available online to the general public, and compared from hospital to hospital,” Dr. Dorry L. Segev explained

Full Post: Obese patients wait longer for liver transplant

By Will Dunham WASHINGTON (Reuters) - Men and women who get heart transplants are more likely to die when the donor was of the opposite sex, U.S. researchers said on Wednesday. The cause is not clear but could be due to size differences in the heart — men’s tend to be larger — or certain hormonal and

Full Post: Risks seen in opposite-sex heart transplants

NEW YORK (Reuters Health) - Advanced donor age, per se, does not adversely affect the transplant recipient or the survival of the organ after liver transplantation, according to a report in the Journal of the American College of Surgeons. Previous reports have indicated that the age of the donor — older than 60 years - contributes

Full Post: Liver transplants from elderly donors are safe

Site Navigation

Most Read